Kim Jee-Hee

3 weeks ago | pulse.mk.co.kr | Kim Jee-Hee |Kim Jee-hee |Lee Eun-joo

Rznomics Inc., a South Korean biotech company that develops RNA-based gene therapies for cancers, announced on Thursday that it signed a technology transfer agreement with U.S. pharmaceutical giant Eli Lilly & Co. to develop RNA-based therapeutics. The two companies will collaborate to develop RNA-editing therapies for hereditary hearing loss using Rznomics’ trans-splicing ribozyme platform.

1 month ago | koreajoongangdaily.joins.com | Kim Jee-Hee |Kim Jee-hee

Home > National > Social Affairs dictionary Audio report: written by reporters, read by AI   The Korean Air Force said Saturday that it retrieved two gun pods that accidentally dropped from a KA-1 light attack aircraft during training the previous night.   A gun pod is a type of container for holding machine guns. The pods contained machine guns and approximately 500 rounds of 12.7-millimeter (0.5-inch) live ammunitions.

1 month ago | koreajoongangdaily.joins.com | Kim Jee-Hee |Kim Jee-hee

Singer Jang Hyun-seung opened up his official YouTube channel, Jang Hyun Seung, on Friday, ahead of the release of his new song “Orbit” scheduled for April 29.   The channel can be found with YouTube handle @JangHyunSeung_Official.   One 16-second introduction video has been uploaded on the channel as of press time Saturday.   The video, consisting of a series of images transitioning quickly, shows Jang’s identity as an artist, the artist's PR agency said in a release Saturday.

1 month ago | koreajoongangdaily.joins.com | Kim Jee-Hee |Kim Jee-hee

A man in his 20s was sentenced to 10 months in prison for blackmailing a woman out of tens of millions of won after falsely claiming she had given him a sexually transmitted infection after they had sex.   The Masan branch of Changwon District Court in South Gyeongsang handed down the sentence Saturday, finding the man guilty of blackmailing and related charges.   The court also ordered the defendant to complete a 40-hour stalking treatment program.

2 months ago | pulse.mk.co.kr | Kim Jee-Hee |Kim Jee-hee |Lee Eun-joo

South Korean bio venture ABL Bio Inc. has landed a licensing agreement worth over 4 trillion won ($2.7 billion) with GSK Plc, allowing GSK to develop novel medicines for neurodegenerative diseases by using ABL Bio’s blood-brain barrier (BBB) shuttle platform, Grabody-B. This is ABL Bio’s first export of a platform technology rather than a specific drug candidate, raising expectations for faster commercialization of the platform moving forward.